An in-depth analysis of the strategic positioning, product matrix, and competitive landscape of Anthropic, Google Gemini, and OpenAI across core industries including finance, healthcare, legal, coding, security, and science. As of May 31, 2026.
The enterprise LLM market landscape is undergoing a structural reversal — Anthropic has surpassed OpenAI in actual enterprise spend for the first time, and differentiated channel strategies have become the biggest dividing line among the three companies.
vs 2023: Anthropic 12%→40% (↑3×) OpenAI 50%→27% (↓halved) Google 7%→21% (↑3×)
Narrow-and-deep route: plugin + data partners + PE channel. Claude Cowork unified architecture, Moody's/S&P/FactSet native integration, Blackstone-Goldman $1.5B JV, $100M Partner Network
Horizontal platform + Workspace + government channel. GSA OneGov $0.47/agency, DoW 3M military/civilian, Gemini Enterprise Agent Platform, Co-Scientist exclusively owns the science vertical
Consumer flywheel → industry products → DeployCo PE three-layer funnel. 900M WAU reverse-penetrating enterprise, Plaid exclusive personal finance integration, DeployCo 17.5% guaranteed floor locking 2000+ PE portfolio companies
| Anthropic | OpenAI | ||
|---|---|---|---|
| Cloud Distribution | Only frontier model simultaneously on AWS Bedrock ↗ + GCP Vertex ↗ + Azure Foundry ↗ | Vertex AI exclusively distributes Gemini ↗; Workspace 6M+ enterprise embedded | Azure OpenAI Service as primary channel ↗ |
| Consulting Channel | Deloitte 470K, KPMG 280K, PwC 470K, Accenture, Cognizant 350K ↗ | — | McKinsey, Capgemini (DeployCo investors), PwC 100K seats ↗ |
| PE/Asset Mgmt JV | Blackstone + H&F + Goldman $1.5B JV ↗ 2026-05-04 · Claude engineers embedded into PE portfolio companies |
— | DeployCo $10B (TPG + Bain + Brookfield) ↗ 2026-05-16 · 17.5%/5yr annualized guaranteed return |
| Government Channel | ~$1/agency promotional pricing | GSA OneGov $0.47/agency ↗ DoW 3M military/civilian, FDA, DOT |
ChatGPT Gov dedicated deployment · ~$1/agency |
| Data Partners | Moody's (600M companies), LSEG, S&P, FactSet, PitchBook, Morningstar ↗ Verisk, ClinicalTrials.gov, Medidata |
— | Plaid (12,000+ financial institutions, exclusive) ↗ b.well (2.2M healthcare providers) |
PE/Investment Bank JV channel ↗ (Blackstone/H&F/Goldman) · Moody's native app ↗ · Life Sciences depth (AstraZeneca/Sanofi/Novo Nordisk) · Harvey BigLaw Bench 90.9% ↗
Co-Scientist scientific hypothesis generation ↗ (Nature paper) · US Federal Government DoW 3M personnel ↗ · Workspace 6M+ enterprise embed · MedGemma 27B open-source base ↗
Consumer-grade personal finance (Plaid exclusive) ↗ · ChatGPT Health consumer ↗ (230M WAU) · DeployCo PE mandatory deployment ↗ (2000+ portfolio companies)
Key Industry Benchmark Score Comparison · ⚠ Some are vendor self-reported; refer to independent evaluations
Claude Opus 4.7; o3 at similar level; other models mostly <30%
MedGemma open-source base; Baichuan focused on Chinese medical scenarios ↗
⚠ Mythos withheld due to "excessive capability" ↗, true capability likely higher
LM Council 2026-05 ↗ · Gemini 3.5 Flash TB2.1: 76.2% · Claude Code $2.5B ↗
Google has no vertical legal product; Harvey primarily uses Claude, has abandoned its own fine-tuned model ↗
OpenAI exclusive; Plaid exclusive integration; launched 2026/5/15
AI-native vertical products replacing traditional SaaS has shifted from a "threat narrative" to "financial data." All six stock impacts occurred on the same day or day after an AI product launch — the market is real-time repricing the entire industry software stack.
Leading Chinese LLM Company Vertical Product Landscape (2025–26)
2.4T parameters · Qianfan platform 760K+ enterprises · Faxingbao (legal) · Comate (coding, 10M+ developers) · 200M MAU
Bailian platform · Tongyi Farui (citation benchmark 64.26 surpassing OpenAI 57.56) · Tongyi Renxin (health) · Tongyi Lingma (coding) · HF 200,000+ model variants ↗
Finance AI 100+ scenarios (SSE/SZSE/ICBC/CICC) · Joint ICU critical care model with Mindray (Nature Medicine) ↗ · Overseas clients YoY doubled
MaaS market share 49.5% ↗ · HiAgent China's #1 agent contract · DAU 100M+ · Token volume 16T→120T/day
LiveCodeBench v6 #1 · HLE #1 · 85% ToG revenue · AutoGLM mobile agent · GLM-4.6 introduction ↗
ALL-IN on healthcare · HealthBench M3 65.1 ↗ · Hallucination rate 3.5% · Beijing Children's Hospital partnership · Valuation ¥20B (~$2.9B) · Wang Xiaochuan explicitly benchmarking
ARR $200M · Valuation $20B+ ↗ · 300 sub-agent parallel · 13-hour continuous coding · Positioned for financial research + software development
Open-source horizontal · No branded vertical SKU · In talks for $30–40B valuation · Indirect deployment through partners (Tesla/cloud providers)
Aside from Baichuan's ALL-IN on healthcare, no company has produced a clearly branded four-in-one package ("ERNIE for Finance" or "Tongyi for Healthcare": model + connectors + agent library + JV channel). Most remain at the two-layer "MaaS platform + industry app" structure.
Baichuan M2/M3, GLM-4.6 (MIT), Qwen3, DeepResearch (Apache 2.0) ↗ all drive localized deployment via open source, the exact opposite of Anthropic's closed-source approach. Google MedGemma's open-source strategy ↗ most closely resembles the Chinese vendor path.
OpenAI DeployCo (17.5% guaranteed return + 2000+ portfolio companies) ↗, Anthropic-Blackstone JV ↗ — these structures cannot currently be replicated in China. The current approach relies on state-owned funds + strategic investment, with industry execution still偏向 project-based delivery.
First published 2026-05-30